Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment

NCT00167557 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The PI left the institution.

Conditions

Hepatitis C

Interventions

DRUG: Pegylated Interferon
DRUG: Ribavirin
PROCEDURE: Liver Biopsy

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]